Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

687 studies match

clinicaltrialsPublishedShowing 251–300 of 687 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06632951	Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)(LIVIGNO-3)	active not recruiting	Phase 2	150	AbbVieINDUSTRY	8	Aug 11, 2025	clinicaltrials
NCT05011058	An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas(NAVAL-1)	terminated	Phase 2	102	Viracta Therapeutics, Inc.